These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11315625)
1. Comparative ultrastructural study of cytotoxic granules in nasal natural killer cell lymphoma, intestinal T-cell lymphoma, and anaplastic large cell lymphoma. Sadahira Y; Akisada K; Sugihara T; Hata S; Uehira K; Muraki N; Manabe T Virchows Arch; 2001 Mar; 438(3):280-8. PubMed ID: 11315625 [TBL] [Abstract][Full Text] [Related]
2. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Chiang AK; Chan AC; Srivastava G; Ho FC Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478 [TBL] [Abstract][Full Text] [Related]
3. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330 [TBL] [Abstract][Full Text] [Related]
5. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382 [TBL] [Abstract][Full Text] [Related]
6. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression. Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738 [TBL] [Abstract][Full Text] [Related]
7. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388 [TBL] [Abstract][Full Text] [Related]
9. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677 [TBL] [Abstract][Full Text] [Related]
11. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360 [TBL] [Abstract][Full Text] [Related]
12. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types. Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306 [TBL] [Abstract][Full Text] [Related]
13. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791 [TBL] [Abstract][Full Text] [Related]
14. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Ng CS; Lo ST; Chan JK; Chan WC Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933 [TBL] [Abstract][Full Text] [Related]
15. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology. Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578 [TBL] [Abstract][Full Text] [Related]
16. Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma. Perambakam S; Naresh K; Nerurkar A; Nadkarni J Pathol Oncol Res; 2000; 6(2):114-7. PubMed ID: 10936786 [TBL] [Abstract][Full Text] [Related]
17. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Haedicke W; Ho FC; Chott A; Moretta L; Rüdiger T; Ott G; Müller-Hermelink HK Blood; 2000 Jun; 95(11):3628-30. PubMed ID: 10828054 [TBL] [Abstract][Full Text] [Related]
18. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340 [TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]